Trial Profile
Randomized Controlled Study of Dipeptidyl Peptidase-4 (DPP4) Inhibitor (Sitagliptin) Therapy in the Inpatient Management of Patients With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary) ; Insulin glargine; Insulin lispro
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 24 Jun 2013 Preliminary results presented at the 73rd Annual Scientific Sessions of the American Diabetes Association.
- 16 Jun 2011 New trial record
- 16 Jun 2011 New trial record